Rroid2 regulates effector-to-memory CD8 + T cell differentiation during infection in vivo
Proceedings of the National Academy of Sciences · 2025
DOI: 10.1073/pnas.2503450122 ↗Kurz gefasst
Fachartikel in der Zeitschrift Proceedings of the National Academy of Sciences, 2025. Verfasst von Julia Erber und 10 weiteren Autor:innen. Beteiligte Einrichtung: Center for Cancer Research, Medical University of Vienna and Comprehensive Cancer Center, Vienna 1090, Austria. Hauptthemen laut MEDLINE: CD8-Positive T-Lymphocytes, Cell Differentiation, Immunologic Memory, RNA, Long Noncoding. Die Arbeit nennt 70 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Austrian Science Fund (FWF).
Abstract (Originalsprache)
CD8 + T cell differentiation has been associated with changes in the expression of long noncoding RNAs (lncRNAs). Yet, which and how lncRNAs regulate CD8 + T cell responses following infection in vivo remains incompletely understood. We performed deep RNA-seq to map the lncRNA expression landscape of CD8 + T cell subsets during infection and generated lncRNA knockout mouse models to evaluate the in vivo relevance of six lncRNAs. We identified Rroid2 to regulate effector CD8 + T cell function and effector-to-memory differentiation. Rroid2 -deficient mice displayed increased CD44 dim Foxp3 + regulatory T cells while the development of other immune cells, such as natural killer cells, was not affected. In CD8 + T cells, Rroid2 deficiency resulted in a fine-tuned downregulation of transcription factors Id2 and T-bet and impaired KLRG1 + and KLRG1 − effector CD8 + T cell proliferation and cytotoxicity as well as effector-to-memory CD8 + T cell differentiation. The human orthologue of Rroid2 , LINC01814 , is also upstream of the transcriptional regulator ID2 and is highly expressed in human memory CD8 + T cells. Taken together, Rroid2 represents a key regulatory layer that controls CD8 + T cell differentiation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Center for Cancer Research, Medical University of Vienna and Comprehensive Cancer Center, Vienna 1090, Austria.
- Department of Immunobiology, Yale School of Medicine, New Haven, CT 06520.
- HHMI, Yale School of Medicine, New Haven, CT 06520.
- Department of Stem Cell and Regenerative Biology, Harvard University, Cambridge, MA 02138.
- Broad Institute of Massachusetts Institute of Technology and Harvard, Cambridge, MA 02142.
- Department of Neuroscience, Johns Hopkins University, Baltimore, MD 21205.
ORCID-Profile: Julia Erber, Carmen Stecher, Valerie Plajer, Loyal A Goff, Iros Barozzi, Thomas Mohr, John L Rinn, Richard A Flavell, Dietmar Herndler-Brandstetter
Förderung
- Austrian Science Fund (FWF)
Zitieren
APA
Erber, J., Stecher, C., Plajer, V., Braun, N., Mallard, W., Goff, L. A., Barozzi, I., Mohr, T., Rinn, J. L., Flavell, R. A., & Herndler-Brandstetter, D. (2025). Rroid2 regulates effector-to-memory CD8 + T cell differentiation during infection in vivo. Proceedings of the National Academy of Sciences. https://doi.org/10.1073/pnas.2503450122
Vancouver
Erber J, Stecher C, Plajer V, Braun N, Mallard W, Goff LA, et al. Rroid2 regulates effector-to-memory CD8 + T cell differentiation during infection in vivo. Proceedings of the National Academy of Sciences. 2025. doi:10.1073/pnas.2503450122
BibTeX
@article{Erber2025,
author = {Erber, Julia and Stecher, Carmen and Plajer, Valerie and Braun, Nina and Mallard, William and Goff, Loyal A and Barozzi, Iros and Mohr, Thomas and Rinn, John L and Flavell, Richard A and Herndler-Brandstetter, Dietmar},
title = {Rroid2 regulates effector-to-memory CD8 + T cell differentiation during infection in vivo},
journal = {Proceedings of the National Academy of Sciences},
year = {2025},
doi = {10.1073/pnas.2503450122}
}
EUVIMED